Professor of Neurology; Director, Norman Fixel Institute for Neurological Diseases, UC Irvine; Senior Investigator, exPDite-2 trial
Appears in 1 story
Leading Phase I embryonic stem cell trial for Parkinson's; presenting 36-month safety and efficacy data
For more than 50 years, Parkinson's disease treatment has meant managing symptoms with medication—not addressing the root cause: the death of dopamine-producing brain cells. Now, clinical trials are testing whether stem cell therapies can actually replace those lost neurons.
Updated May 27
No stories match your search
Try a different keyword
How would you like to describe your experience with the app today?
